David Henry Mack - 18 Oct 2023 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Signature
/s/ David H. Mack
Issuer symbol
PMVP
Transactions as of
18 Oct 2023
Net transactions value
+$105,156
Form type
4
Filing time
13 Nov 2023, 16:21:30 UTC
Previous filing
08 Aug 2023
Next filing
22 Jan 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PMVP Common Stock Options Exercise $105,156 +198,407 +120% $0.5300* 363,877 18 Oct 2023 Direct
transaction PMVP Common Stock Gift $0 -85,307 -23% $0.000000 278,570 10 Nov 2023 Direct
transaction PMVP Common Stock Gift $0 +85,307 +107% $0.000000 165,307 10 Nov 2023 See footnote F1
holding PMVP Common Stock 147,915 18 Oct 2023 See footnote F2
holding PMVP Common Stock 56,978 18 Oct 2023 See footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMVP Employee Stock Option (right to buy) Options Exercise $0 -198,407 -64% $0.000000 109,459 07 Aug 2023 Common Stock 198,407 $0.5300 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F2 The shares are held of record by The Mack-Mulligan Revocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F3 The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F4 The shares subject to the option are fully vested and immediately exercisable.